Dutasteride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241040

Publication Date:

September 6, 2024

Pages:

121

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global market for Dutasteride was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Dutasteride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dutasteride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Dutasteride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Dutasteride include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dutasteride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dutasteride by region & country, by Type, and by Application.
The Dutasteride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride.
Market Segmentation
By Company
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical
Segment by Type:
Type I
Type II
Segment by Application
Hospital
Drug Store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dutasteride in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Dutasteride Product Introduction
1.2 Global Dutasteride Market Size Forecast
1.2.1 Global Dutasteride Sales Value (2019-2030)
1.2.2 Global Dutasteride Sales Volume (2019-2030)
1.2.3 Global Dutasteride Sales Price (2019-2030)
1.3 Dutasteride Market Trends & Drivers
1.3.1 Dutasteride Industry Trends
1.3.2 Dutasteride Market Drivers & Opportunity
1.3.3 Dutasteride Market Challenges
1.3.4 Dutasteride Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dutasteride Players Revenue Ranking (2023)
2.2 Global Dutasteride Revenue by Company (2019-2024)
2.3 Global Dutasteride Players Sales Volume Ranking (2023)
2.4 Global Dutasteride Sales Volume by Company Players (2019-2024)
2.5 Global Dutasteride Average Price by Company (2019-2024)
2.6 Key Manufacturers Dutasteride Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dutasteride Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dutasteride
2.9 Dutasteride Market Competitive Analysis
2.9.1 Dutasteride Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dutasteride Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Type I
3.1.2 Type II
3.2 Global Dutasteride Sales Value by Type
3.2.1 Global Dutasteride Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dutasteride Sales Value, by Type (2019-2030)
3.2.3 Global Dutasteride Sales Value, by Type (%) (2019-2030)
3.3 Global Dutasteride Sales Volume by Type
3.3.1 Global Dutasteride Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dutasteride Sales Volume, by Type (2019-2030)
3.3.3 Global Dutasteride Sales Volume, by Type (%) (2019-2030)
3.4 Global Dutasteride Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Dutasteride Sales Value by Application
4.2.1 Global Dutasteride Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dutasteride Sales Value, by Application (2019-2030)
4.2.3 Global Dutasteride Sales Value, by Application (%) (2019-2030)
4.3 Global Dutasteride Sales Volume by Application
4.3.1 Global Dutasteride Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dutasteride Sales Volume, by Application (2019-2030)
4.3.3 Global Dutasteride Sales Volume, by Application (%) (2019-2030)
4.4 Global Dutasteride Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dutasteride Sales Value by Region
5.1.1 Global Dutasteride Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dutasteride Sales Value by Region (2019-2024)
5.1.3 Global Dutasteride Sales Value by Region (2025-2030)
5.1.4 Global Dutasteride Sales Value by Region (%), (2019-2030)
5.2 Global Dutasteride Sales Volume by Region
5.2.1 Global Dutasteride Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dutasteride Sales Volume by Region (2019-2024)
5.2.3 Global Dutasteride Sales Volume by Region (2025-2030)
5.2.4 Global Dutasteride Sales Volume by Region (%), (2019-2030)
5.3 Global Dutasteride Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dutasteride Sales Value, 2019-2030
5.4.2 North America Dutasteride Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dutasteride Sales Value, 2019-2030
5.5.2 Europe Dutasteride Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dutasteride Sales Value, 2019-2030
5.6.2 Asia Pacific Dutasteride Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dutasteride Sales Value, 2019-2030
5.7.2 South America Dutasteride Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dutasteride Sales Value, 2019-2030
5.8.2 Middle East & Africa Dutasteride Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dutasteride Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dutasteride Sales Value
6.2.1 Key Countries/Regions Dutasteride Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dutasteride Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dutasteride Sales Value, 2019-2030
6.3.2 United States Dutasteride Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dutasteride Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dutasteride Sales Value, 2019-2030
6.4.2 Europe Dutasteride Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dutasteride Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dutasteride Sales Value, 2019-2030
6.5.2 China Dutasteride Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dutasteride Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dutasteride Sales Value, 2019-2030
6.6.2 Japan Dutasteride Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dutasteride Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dutasteride Sales Value, 2019-2030
6.7.2 South Korea Dutasteride Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dutasteride Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dutasteride Sales Value, 2019-2030
6.8.2 Southeast Asia Dutasteride Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dutasteride Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dutasteride Sales Value, 2019-2030
6.9.2 India Dutasteride Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dutasteride Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Company Information
7.1.2 GSK Introduction and Business Overview
7.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GSK Dutasteride Product Offerings
7.1.5 GSK Recent Development
7.2 Bionpharma
7.2.1 Bionpharma Company Information
7.2.2 Bionpharma Introduction and Business Overview
7.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bionpharma Dutasteride Product Offerings
7.2.5 Bionpharma Recent Development
7.3 Rising Pharmaceuticals
7.3.1 Rising Pharmaceuticals Company Information
7.3.2 Rising Pharmaceuticals Introduction and Business Overview
7.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Rising Pharmaceuticals Dutasteride Product Offerings
7.3.5 Rising Pharmaceuticals Recent Development
7.4 Teva
7.4.1 Teva Company Information
7.4.2 Teva Introduction and Business Overview
7.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Teva Dutasteride Product Offerings
7.4.5 Teva Recent Development
7.5 Mylan
7.5.1 Mylan Company Information
7.5.2 Mylan Introduction and Business Overview
7.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Mylan Dutasteride Product Offerings
7.5.5 Mylan Recent Development
7.6 Zydus
7.6.1 Zydus Company Information
7.6.2 Zydus Introduction and Business Overview
7.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Zydus Dutasteride Product Offerings
7.6.5 Zydus Recent Development
7.7 Amneal Pharma
7.7.1 Amneal Pharma Company Information
7.7.2 Amneal Pharma Introduction and Business Overview
7.7.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Amneal Pharma Dutasteride Product Offerings
7.7.5 Amneal Pharma Recent Development
7.8 Apotex
7.8.1 Apotex Company Information
7.8.2 Apotex Introduction and Business Overview
7.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Apotex Dutasteride Product Offerings
7.8.5 Apotex Recent Development
7.9 Marksans Pharma
7.9.1 Marksans Pharma Company Information
7.9.2 Marksans Pharma Introduction and Business Overview
7.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Marksans Pharma Dutasteride Product Offerings
7.9.5 Marksans Pharma Recent Development
7.10 Breckenridge Pharmaceutical
7.10.1 Breckenridge Pharmaceutical Company Information
7.10.2 Breckenridge Pharmaceutical Introduction and Business Overview
7.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Breckenridge Pharmaceutical Dutasteride Product Offerings
7.10.5 Breckenridge Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Dutasteride Industrial Chain
8.2 Dutasteride Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dutasteride Sales Model
8.5.2 Sales Channel
8.5.3 Dutasteride Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂